Showing results (2261-2270 of 3,641) with videos related to
Sort By:
Pageof 365
Breast (Edinburgh, Scotland)|December 3, 2013
The impact of a breast cancer diagnosis in young women on their relationship with their mothersAsma Ali, Karen Fergus, Frances C Wright, et al.Breast (Edinburgh, Scotland)|November 13, 2013
Emerging nanotherapeutic strategies in breast cancerElvin Blanco, Mauro FerrariBreast (Edinburgh, Scotland)|December 10, 2013
High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in luminal B HER2 negative and node-positive breast cancerCarmen Criscitiello, Davide Disalvatore, Michele De Laurentiis, et al.Breast (Edinburgh, Scotland)|December 10, 2013
Incremental effect from integrating 3D-mammography (tomosynthesis) with 2D-mammography: Increased breast cancer detection evident for screening centres in a population-based trialFrancesca Caumo, Daniela Bernardi, Stefano Ciatto, et al.Breast (Edinburgh, Scotland)|October 1, 2013
Personalizing extent of breast cancer surgery according to molecular subtypesMonica MorrowBreast (Edinburgh, Scotland)|October 1, 2013
Close/positive margins after breast-conserving therapy: additional resection or no resection?William C WoodBreast (Edinburgh, Scotland)|October 1, 2013
Partial breast re-irradiation for local recurrence of breast carcinoma: Benefit and long term side effectsFelix Sedlmayer, Franz Zehentmayr, Gerd FastnerBreast (Edinburgh, Scotland)|October 1, 2013
Follow-up tests to detect recurrent disease: patient's reassurance or medical need?Ian E Smith, Gaia SchiavonBreast (Edinburgh, Scotland)|October 1, 2013
Influence of genomics on adjuvant treatments for pre-invasive and invasive breast cancerMaysa Abu-Khalf, Lajos PusztaiBreast (Edinburgh, Scotland)|October 1, 2013
Phase II study of liposome-encapsulated doxorubicin plus cyclophosphamide, followed by sequential trastuzumab plus docetaxel as primary systemic therapy for breast cancer patients with HER2 overexpression or amplificationS Saracchini, L Foltran, F Tuccia, et al.Pageof 365